Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Elkins

Showing results (271-280 of 352) with videos related to

Pageof 36
Sort By:
The Journal of Infectious Diseases|April 1, 1996
Live subgroup B respiratory syncytial virus vaccines that are attenuated, genetically stable, and immunogenic in rodents and nonhuman primatesJ E Crowe, P T Bui, C Y Firestone, et al.
Journal of Virology|September 12, 2000
Recombinant respiratory syncytial virus that does not express the NS1 or M2-2 protein is highly attenuated and immunogenic in chimpanzeesM N Teng, S S Whitehead, A Bermingham, et al.
Physical Therapy|December 15, 2010
CENTRAL, PEDro, PubMed, and EMBASE are the most comprehensive databases indexing randomized controlled trials of physical therapy interventionsZoe A Michaleff, Leonardo O P Costa, Anne M Moseley, et al.
Journal of Virology|January 5, 2002
Mucosal immunization of rhesus monkeys against respiratory syncytial virus subgroups A and B and human parainfluenza virus type 3 by using a live cDNA-derived vaccine based on a host range-attenuated bovine parainfluenza virus type 3 vector backboneAlexander C Schmidt, Daniel R Wenzke, Josephine M McAuliffe, et al.
Journal of Virology|November 13, 1999
Replacement of the F and G proteins of respiratory syncytial virus (RSV) subgroup A with those of subgroup B generates chimeric live attenuated RSV subgroup B vaccine candidatesS S Whitehead, M G Hill, C Y Firestone, et al.
Journal of Virology|February 1, 1995
Induction of AIDS by simian immunodeficiency virus from an African green monkey: species-specific variation in pathogenicity correlates with the extent of in vivo replicationV M Hirsch, G Dapolito, P R Johnson, et al.
The Journal of Primary Prevention|September 6, 2013
The association between problematic parental substance use and adolescent substance use in an ethnically diverse sample of 9th and 10th gradersRyan C Shorey, Paula J Fite, Sara R Elkins, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 22, 2017
Cholesterol-binding site of the influenza M2 protein in lipid bilayers from solid-state NMRMatthew R Elkins, Jonathan K Williams, Martin D Gelenter, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 31, 2019
In vitro 0N4R tau fibrils contain a monomorphic β-sheet core enclosed by dynamically heterogeneous fuzzy coat segmentsAurelio J Dregni, Venkata S Mandala, Haifan Wu, et al.
Journal of Virology|November 23, 2000
Wide range of viral load in healthy african green monkeys naturally infected with simian immunodeficiency virusS Goldstein, I Ourmanov, C R Brown, et al.
Pageof 36

Showing results (271-280 of 352) with videos related to

Sort By:
Pageof 36
The Journal of Infectious Diseases|April 1, 1996
Live subgroup B respiratory syncytial virus vaccines that are attenuated, genetically stable, and immunogenic in rodents and nonhuman primatesJ E Crowe, P T Bui, C Y Firestone, et al.
Journal of Virology|September 12, 2000
Recombinant respiratory syncytial virus that does not express the NS1 or M2-2 protein is highly attenuated and immunogenic in chimpanzeesM N Teng, S S Whitehead, A Bermingham, et al.
Physical Therapy|December 15, 2010
CENTRAL, PEDro, PubMed, and EMBASE are the most comprehensive databases indexing randomized controlled trials of physical therapy interventionsZoe A Michaleff, Leonardo O P Costa, Anne M Moseley, et al.
Journal of Virology|January 5, 2002
Mucosal immunization of rhesus monkeys against respiratory syncytial virus subgroups A and B and human parainfluenza virus type 3 by using a live cDNA-derived vaccine based on a host range-attenuated bovine parainfluenza virus type 3 vector backboneAlexander C Schmidt, Daniel R Wenzke, Josephine M McAuliffe, et al.
Journal of Virology|November 13, 1999
Replacement of the F and G proteins of respiratory syncytial virus (RSV) subgroup A with those of subgroup B generates chimeric live attenuated RSV subgroup B vaccine candidatesS S Whitehead, M G Hill, C Y Firestone, et al.
Journal of Virology|February 1, 1995
Induction of AIDS by simian immunodeficiency virus from an African green monkey: species-specific variation in pathogenicity correlates with the extent of in vivo replicationV M Hirsch, G Dapolito, P R Johnson, et al.
The Journal of Primary Prevention|September 6, 2013
The association between problematic parental substance use and adolescent substance use in an ethnically diverse sample of 9th and 10th gradersRyan C Shorey, Paula J Fite, Sara R Elkins, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 22, 2017
Cholesterol-binding site of the influenza M2 protein in lipid bilayers from solid-state NMRMatthew R Elkins, Jonathan K Williams, Martin D Gelenter, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 31, 2019
In vitro 0N4R tau fibrils contain a monomorphic β-sheet core enclosed by dynamically heterogeneous fuzzy coat segmentsAurelio J Dregni, Venkata S Mandala, Haifan Wu, et al.
Journal of Virology|November 23, 2000
Wide range of viral load in healthy african green monkeys naturally infected with simian immunodeficiency virusS Goldstein, I Ourmanov, C R Brown, et al.
Pageof 36